Clinical Trial Update: Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports assessment of cutaneous treatment efficacy of Roseomonas for atopic dermatitis in Phase 1/Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Roseomonas

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED